Future research on CD25 in cancer is focused on developing more selective and effective therapies. This includes the design of bispecific antibodies that target CD25 and another molecule to enhance specificity, as well as combination therapies that target multiple pathways in the tumor microenvironment. Furthermore, understanding the role of CD25 in different types of cancer and patient populations will help tailor personalized immunotherapeutic strategies.
